GO:0046326 positive regulation of D-glucose import across plasma membrane: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046326 describes any process that increases the import of D-glucose across the plasma membrane into a cell.
• This term is a biological process and is distinct from glucose metabolism or glucose sensing; it specifically covers the upregulation of glucose uptake.
• Key molecular players include glucose transporters (GLUTs/SLC2A family), insulin receptor signaling, and AMP-activated protein kinase (AMPK).
• Dysregulation of glucose import is linked to insulin resistance, type 2 diabetes, cancer (Warburg effect), and cardiac hypertrophy.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect causal roles of genes in this process.
• Studying this term requires combining transport assays, live-cell imaging, and transcriptomic/proteomic readouts.
Description
The Gene Ontology (GO) term GO:0046326, positive regulation of D-glucose import across plasma membrane, defines any biological process that activates or increases the frequency, rate, or extent of glucose import into a cell. Glucose is the primary energy substrate for most mammalian cells, and its uptake is tightly controlled by hormones, nutrients, and stress signals. This GO term captures the regulatory layer that ensures glucose supply meets metabolic demand, a process fundamental to physiology and disease. Researchers study GO:0046326 to understand how cells adapt to changing energy needs, how insulin and exercise stimulate glucose uptake, and how cancer cells reprogram metabolism to sustain growth. The term encompasses signaling cascades, transporter trafficking, and transcriptional programs that converge on the plasma membrane to enhance glucose influx. Because defects in glucose import contribute to insulin resistance, diabetes, and tumor progression, this GO term is a focal point for therapeutic target discovery and biomarker development. Experimental models that manipulate candidate regulators are essential to establish causality and to identify druggable nodes.
positive regulation of D-glucose import across plasma membrane At A Glance
| GO ID | GO:0046326 |
|---|---|
| GO term | positive regulation of D-glucose import across plasma membrane |
| Ontology | biological_process |
| Synonym | activation of glucose import; positive regulation of glucose import; positive regulation of glucose uptake; stimulation of glucose import; up regulation of glucose import; up-regulation of glucose import; upregulation of glucose import |
| Major function | Upregulation of glucose transport into the cell in response to signals such as insulin, energy stress, or growth factors |
| Related cellular component | Plasma membrane, glucose transporter-containing vesicles, endosomes |
| Related molecular function | Glucose transporter activity, insulin receptor signaling, AMPK signaling |
| Disease relevance | Insulin resistance, type 2 diabetes, cancer, cardiac hypertrophy |
What Is GO:0046326?
GO:0046326 is a biological process term that describes any mechanism that positively regulates the import of the hexose monosaccharide D-glucose across the plasma membrane into a cell. It includes activation, stimulation, upregulation, or increased frequency/rate/extent of glucose uptake. This term does not cover glucose metabolism, glucose sensing, or transport of other sugars; it is specifically about the regulatory events that enhance glucose import.
Why Is positive regulation of D-glucose import across plasma membrane Important in Cell Biology?
GO:0046326 is critical because glucose import is the rate-limiting step for glucose utilization in many cell types, and its positive regulation determines whether cells can meet metabolic demands during growth, stress, or hormonal stimulation. Dysregulation of this process underlies major human diseases, including type 2 diabetes, cancer, and cardiovascular disorders, making it a prime target for therapeutic intervention.
• Controls systemic glucose homeostasis and insulin sensitivity.
• Supports rapid energy supply for proliferating cancer cells (Warburg effect).
• Mediates exercise-induced glucose uptake in skeletal muscle.
• Regulates cardiac metabolism and contributes to hypertrophic growth.
• Influences neuronal energy supply and synaptic function.
• Provides a mechanism for immune cell activation and inflammatory responses.
• Serves as a target for anti-diabetic drugs (e.g., metformin, thiazolidinediones).
• Offers biomarkers for metabolic disorders and cancer diagnosis.
What Happens During positive regulation of D-glucose import across plasma membrane?
Signal Reception and Transduction
In simple terms: A signal from outside the cell tells the cell to take in more glucose.
Positive regulation begins when extracellular signals such as insulin, growth factors, or energy stress (e.g., AMP/ATP ratio) bind to receptors or activate sensors on the plasma membrane. Insulin binding to the insulin receptor triggers autophosphorylation and recruitment of insulin receptor substrates (IRS1/2), leading to activation of phosphoinositide 3-kinase (PI3K) and Akt. Concurrently, energy stress activates AMP-activated protein kinase (AMPK), which can also promote glucose uptake. These signaling events initiate downstream cascades that ultimately increase glucose import.
Transporter Trafficking and Membrane Insertion
In simple terms: Glucose transporters are moved to the cell surface to let more glucose in.
A key step is the translocation of glucose transporters (GLUTs, primarily GLUT4 in muscle and adipose tissue) from intracellular storage vesicles to the plasma membrane. Akt phosphorylates AS160 (TBC1D4), a Rab GTPase-activating protein, relieving inhibition of Rab proteins that mediate vesicle fusion. This leads to docking and fusion of GLUT4-containing vesicles with the plasma membrane, increasing the number of transporters available for glucose uptake. In other cell types, GLUT1, GLUT2, or GLUT3 may be regulated similarly or through transcriptional mechanisms.
Transcriptional and Translational Control
In simple terms: The cell can also make more transporter proteins by turning on genes.
Long-term positive regulation involves increased transcription of glucose transporter genes (e.g., SLC2A1, SLC2A4) and glycolytic enzymes. Transcription factors such as HIF-1α (under hypoxia) and ChREBP (in response to glucose) drive expression of these genes. Additionally, mRNA stability and translation of transporter transcripts can be enhanced, further amplifying glucose import capacity.
Feedback and Integration with Metabolism
In simple terms: The cell monitors glucose levels and adjusts uptake to avoid overload.
Positive regulation is balanced by negative feedback loops to prevent glucotoxicity. For example, sustained high glucose can activate mTORC1, which in turn suppresses further glucose uptake through negative feedback on insulin signaling. AMPK acts as a energy sensor that promotes glucose uptake when energy is low but can also limit uptake when energy is restored. Integration with metabolic pathways ensures that glucose import matches cellular needs.
Key Genes Involved in GO:0046326 positive regulation of D-glucose import across plasma membrane
The following genes and proteins are central to the positive regulation of D-glucose import across plasma membrane, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A4 (GLUT4) | Insulin-responsive glucose transporter; translocates to plasma membrane upon stimulation | Key marker of insulin sensitivity; knockout mice show impaired glucose tolerance |
| SLC2A1 (GLUT1) | Basal glucose transporter; often overexpressed in cancer | Target for cancer metabolism studies; knockout is embryonic lethal |
| INSR | Insulin receptor; initiates signaling cascade for glucose uptake | Mutations cause severe insulin resistance; knockout models are diabetic |
| IRS1 | Insulin receptor substrate 1; adaptor for PI3K activation | Polymorphisms linked to type 2 diabetes; knockout mice show insulin resistance |
| IRS2 | Insulin receptor substrate 2; mediates insulin signaling in liver and beta cells | Knockout leads to diabetes; important for beta-cell survival |
| PIK3CA | Catalytic subunit of PI3K; generates PIP3 to recruit Akt | Oncogenic mutations increase glucose uptake; knockout impairs insulin signaling |
| AKT2 | Serine/threonine kinase; phosphorylates AS160 to promote GLUT4 translocation | Knockout mice exhibit insulin resistance; key node in diabetes |
| TBC1D4 (AS160) | Rab GAP; inhibits GLUT4 translocation until phosphorylated by Akt | Mutations associated with insulin resistance; knockout enhances glucose uptake |
| PRKAA1 (AMPKα1) | Energy sensor; promotes glucose uptake during energy stress | Activators (e.g., metformin) require AMPK; knockout blocks exercise-induced uptake |
| PRKAA2 (AMPKα2) | Energy sensor; mediates glucose uptake in muscle | Knockout reduces insulin-stimulated glucose uptake |
| HIF1A | Hypoxia-inducible factor 1α; upregulates GLUT1 and glycolytic genes | Overexpressed in tumors; knockout reduces glucose uptake in hypoxia |
| MYC | Oncogene; enhances glucose uptake and glycolysis | Amplified in many cancers; knockout reverses Warburg effect |
| SLC2A2 (GLUT2) | Bidirectional transporter in liver and pancreatic beta cells | Mutations cause Fanconi-Bickel syndrome; knockout impairs glucose sensing |
| SLC2A3 (GLUT3) | Neuronal glucose transporter; high affinity | Knockout affects neuronal energy supply; linked to neurodegeneration |
| RAB10 | Rab GTPase; mediates GLUT4 vesicle trafficking | Knockdown impairs insulin-stimulated glucose uptake |
| RAB8A | Rab GTPase; involved in GLUT4 translocation | Knockout reduces glucose uptake in adipocytes |
| VAMP2 | SNARE protein; mediates vesicle fusion with plasma membrane | Knockout blocks GLUT4 insertion; used in trafficking studies |
| SNAP23 | SNARE protein; required for GLUT4 vesicle fusion | Knockdown inhibits insulin-stimulated glucose transport |
How Is positive regulation of D-glucose import across plasma membrane Regulated?
Positive regulation of D-glucose import is controlled by a network of signaling pathways. Insulin/IGF-1 signaling through PI3K-Akt is the primary hormonal regulator, promoting GLUT4 translocation and increasing glucose uptake. AMPK acts as an energy sensor, stimulating glucose uptake when cellular energy is low, independent of insulin. mTORC1 integrates nutrient and growth factor signals to modulate glucose import, often through feedback inhibition of insulin signaling. Transcriptional regulators such as HIF-1α and ChREBP adjust transporter expression in response to hypoxia or glucose availability. Additionally, inflammatory cytokines (e.g., TNF-α) can impair glucose uptake, contributing to insulin resistance.
positive regulation of D-glucose import across plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A4 | Type 2 diabetes, insulin resistance | Knockout mouse, adipocyte-specific KO |
| SLC2A1 | Cancer (Warburg effect), GLUT1 deficiency syndrome | Knockout cancer cell lines, xenografts |
| INSR | Severe insulin resistance, diabetes | Liver-specific KO, knock-in of patient mutations |
| AKT2 | Type 2 diabetes, lipodystrophy | Knockout mouse, overexpression in cell lines |
| HIF1A | Cancer, ischemia | Knockout tumor cells, hypoxia models |
Type 2 Diabetes and Insulin Resistance
Impaired positive regulation of glucose import is a hallmark of type 2 diabetes. Defects in insulin signaling (e.g., IRS1, Akt) or GLUT4 trafficking lead to reduced glucose uptake in muscle and adipose tissue, causing hyperglycemia. Chronic inflammation and lipotoxicity further impair these pathways, creating a vicious cycle of insulin resistance. Animal models with knockout of Insr, Irs1, or Akt2 recapitulate key features of diabetes and are used to test therapeutic interventions.
Cancer Metabolism
Cancer cells often upregulate glucose import to support rapid proliferation, a phenomenon known as the Warburg effect. Overexpression of GLUT1 (SLC2A1) and GLUT3 (SLC2A3) is common in many tumors and correlates with poor prognosis. Oncogenes such as MYC and HIF1A drive transporter expression, while tumor suppressors like p53 can inhibit it. Targeting glucose import is a promising therapeutic strategy, and CRISPR knockout of SLC2A1 reduces tumor growth in preclinical models.
Cardiac Hypertrophy and Heart Failure
The heart relies on glucose import for energy, especially during stress. Pathological hypertrophy is associated with increased glucose uptake and a shift from fatty acid oxidation to glycolysis. AMPK and insulin signaling regulate GLUT4 translocation in cardiomyocytes, and their dysregulation contributes to heart failure. Knockout models of Prkaa2 or Slc2a4 show altered cardiac metabolism and increased susceptibility to ischemia.
Neurodegeneration
Neurons require constant glucose supply, and impaired glucose import is linked to neurodegeneration. Reduced GLUT3 (SLC2A3) levels have been observed in Alzheimer's disease brains, and knockout of Slc2a3 in mice leads to neuronal dysfunction. Hypoxia and energy stress can also affect glucose uptake in the brain, contributing to ischemic damage.
From positive regulation of D-glucose import across plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate glucose import? | CRISPR knockout in cell lines (e.g., HeLa, HEK293) followed by glucose uptake assay |
| Does a specific mutation in gene Y affect glucose import? | Point mutation knock-in using CRISPR in patient-derived cells |
| Can overexpression of gene Z enhance glucose uptake? | CRISPRa or lentiviral overexpression in adipocytes or myotubes |
| How does gene W affect GLUT4 trafficking? | Tagged knock-in (e.g., GFP-GLUT4) in muscle cells for live imaging |
| What is the role of gene V in insulin signaling? | Knockout mouse models (conditional or global) |
| Can we identify novel regulators of glucose import? | Genome-wide CRISPR library screening with glucose uptake readout |
How to Study the positive regulation of D-glucose import across plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 2-Deoxyglucose uptake assay | Rate of glucose transport | Assessing insulin sensitivity in cells |
| 2-NBDG flow cytometry | Glucose uptake at single-cell level | CRISPR screen readout |
| GLUT4-GFP live imaging | Transporter translocation to membrane | Studying insulin-stimulated trafficking |
| RNA-seq | Transcriptional changes in transporters and signaling genes | Identifying long-term regulation |
| Phosphoproteomics | Phosphorylation events in signaling pathways | Mapping insulin/AMPK signaling |
| CRISPR knockout screen | Genes required for glucose import | Discovery of novel regulators |
| Western blot | Protein expression and phosphorylation | Validating signaling changes |
| Co-immunoprecipitation | Protein-protein interactions | Identifying transporter complexes |
Glucose Uptake Assays
Direct measurement of glucose import is performed using radiolabeled 2-deoxy-D-[3H]glucose or fluorescent glucose analogs (e.g., 2-NBDG). These assays quantify the rate of glucose uptake in live cells and are the gold standard for assessing positive regulation. They can be combined with CRISPR knockout or overexpression to test gene function.
Live-Cell Imaging of Transporter Trafficking
Tagged glucose transporters (e.g., GLUT4-GFP) allow real-time visualization of vesicle translocation to the plasma membrane. Total internal reflection fluorescence (TIRF) microscopy can capture fusion events at the membrane. This method is essential for studying the dynamic regulation of glucose import.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can identify changes in glucose transporter expression and signaling pathways upon genetic manipulation. Phosphoproteomics reveals post-translational modifications that regulate transporter trafficking. These approaches provide a systems-level view of positive regulation.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens coupled with a glucose uptake readout (e.g., FACS sorting of 2-NBDG-positive cells) can uncover novel regulators of glucose import. This unbiased approach has identified both known and unexpected genes in metabolic pathways.
How CRISPR Can Be Used to Study GO:0046326 positive regulation of D-glucose import across plasma membrane
Knockout
CRISPR knockout is used to delete candidate genes and assess their requirement for positive regulation of glucose import. For example, knocking out SLC2A4 in adipocytes abolishes insulin-stimulated glucose uptake, confirming its essential role. Knockout models can be generated in cell lines or mice, and glucose uptake assays quantify the effect.
Point Mutation
Point mutations identified in patients (e.g., in INSR or AKT2) can be introduced using CRISPR base editing or homology-directed repair to study their impact on glucose import. This approach reveals structure-function relationships and disease mechanisms. For instance, knock-in of a kinase-dead Akt2 mutation impairs glucose uptake.
Knock-in
Knock-in of reporter tags (e.g., GFP) or epitope tags into endogenous loci allows tracking of transporter trafficking and protein interactions. Tagged GLUT4 knock-in mice are widely used to study glucose import in vivo. Knock-in can also be used to overexpress a gene under its native promoter.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to increase gene expression and test whether it enhances glucose import. Overexpression of SLC2A1 in cancer cells increases glucose uptake and supports growth under hypoxia. This approach helps identify rate-limiting steps in the pathway.
How EDITGENE Supports positive regulation of D-glucose import across plasma membrane Research
Researchers studying positive regulation of D-glucose import across plasma membrane-related genes often need to determine whether a candidate gene is causally involved in glucose uptake or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to establish causality, from generating knockout cell lines to creating precise point mutations and knock-in reporters. Our platforms enable functional validation of genes identified in screens, transcriptomic studies, or clinical samples, accelerating discovery in metabolic disease and cancer research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of D-glucose import across plasma membrane research.
Frequently Asked Questions About positive regulation of D-glucose import across plasma membrane
What is GO:0046326?
GO:0046326 is a Gene Ontology biological process term that describes any process that activates or increases the import of D-glucose across the plasma membrane into a cell.
What genes are involved in positive regulation of D-glucose import?
Key genes include SLC2A4 (GLUT4), SLC2A1 (GLUT1), INSR, IRS1, AKT2, TBC1D4 (AS160), PRKAA1/2 (AMPK), and HIF1A, among others.
How is glucose import regulated by insulin?
Insulin binds to the insulin receptor, activating PI3K-Akt signaling, which leads to GLUT4 translocation to the plasma membrane and increased glucose uptake.
What diseases are associated with defective glucose import?
Defective glucose import is linked to type 2 diabetes, insulin resistance, cancer, cardiac hypertrophy, and neurodegeneration.
How can CRISPR be used to study glucose import?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to test the causal role of specific genes in glucose import.
What is the Warburg effect?
The Warburg effect is the observation that cancer cells upregulate glucose uptake and glycolysis even in the presence of oxygen, often through increased expression of glucose transporters like GLUT1.
Which glucose transporter is most important for insulin-stimulated glucose uptake?
GLUT4 (SLC2A4) is the primary insulin-responsive glucose transporter in muscle and adipose tissue.
How is AMPK involved in glucose import?
AMPK is an energy sensor that promotes glucose uptake when cellular energy is low, independent of insulin, by stimulating GLUT4 translocation and glycolysis.
What methods measure glucose import?
Common methods include radiolabeled 2-deoxyglucose uptake assays, fluorescent 2-NBDG flow cytometry, and live-cell imaging of tagged GLUT4.
Can CRISPR screens identify new regulators of glucose import?
Yes, genome-wide CRISPR knockout or activation screens coupled with glucose uptake readouts can uncover novel regulators of this process.
Conclusion
GO:0046326, positive regulation of D-glucose import across plasma membrane, is a fundamental biological process that controls cellular energy supply and is dysregulated in major human diseases. Understanding its molecular players and regulatory mechanisms is essential for developing therapies against diabetes, cancer, and cardiovascular disorders. CRISPR-based models provide powerful tools to establish causality and to discover new therapeutic targets in this pathway.
References
- 1. Pareek M et al.. 2022. Preassembled Cas9 Ribonucleoprotein-Mediated Gene Deletion Identifies the Carbon Catabolite Repressor and Its Target Genes in Coprinopsis cinerea.. Appl Environ Microbiol 88(23):e0094022 PMID: 36374019
